Analysts at Roth Capital issued their Q1 2026 EPS estimates for shares of Uranium Energy in a research report issued to clients and investors on Monday, December 9th. Roth Capital analyst J. Reagor ...
Yext (NYSE:YEXT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday,Benzinga reports. They presently have a $10.50 target ...
RothMKM raised the firm’s price target on Kroger (KR) to $56 from $52 and keeps a Neutral rating on the shares after its Q3 results. With a comp store sales beat, Kroger returned to ...
Days after investment bank RothMKM upgraded its rating on the Tesla Inc. TSLA stock from “neutral” to “buy,” other analysts have hiked price targets. What Happened: Bank of America ...
On Friday, Roth/MKM initiated coverage on shares of CervoMed (NASDAQ:CRVO), a pharmaceutical company, with a Buy rating and a 12-month price target of $45.00. The firm's positive outlook is based ...
RothMKM analyst Boobalan Pachaiyappan last night initiated coverage of Gain Therapeutics (GANX) with a Buy rating and $7 price target The firm says GT-02287, a potential $4B drug that ...